- Long-acting antiretrovirals (LA-ART and LA-PrEP) could significantly help people who use drugs and those experiencing homelessness in managing HIV, as these groups often struggle with the daily routine of oral therapy due to various barriers.
- A study conducted at the Maria X. Martinez Health Resource Center in San Francisco, which focuses on low-barrier access, showed that out of 33 patients receiving LA-ART or LA-PrEP, most achieved viral suppression or maintained their HIV-negative status over the first 24 months.
- The success of this program demonstrates that providing LA antiretrovirals in supportive community settings is feasible and highlights the need for similar initiatives to combat the HIV epidemic among vulnerable populations.